Maplight Therapeutics, Inc. · NASDAQ:MPLT

Kroeger Christopher A. sold 49,744 Maplight Therapeutics, Inc. shares (Form 4)

Traded May 4 to May 6, 2026 · Filed May 6, 2026

From May 4 to May 6, 2026, Kroeger Christopher A. (Director, Chief Executive Officer) sold 49,744 Maplight Therapeutics, Inc. shares at an average US$28.39 for US$1.41M under a trading plan, leaving 1,580,820 shares. Filed May 6, 2026 (Form 4).

Sold
49,744 shares
Price
US$28.39 average (US$27.50 to US$30.08)
Value
US$1.41M
Holding after
1,580,820 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 4, 2026Voting Common StockSale9,136US$27.501,621,428Direct
May 4, 2026Voting Common StockSale5,427US$28.371,616,001Direct
May 4, 2026Voting Common StockSale311US$29.561,615,690Direct
May 4, 2026Voting Common StockSale697US$30.081,614,993Direct
May 5, 2026Voting Common StockSale9,544US$28.121,605,449Direct
May 5, 2026Voting Common StockSale928US$29.001,604,521Direct
May 6, 2026Voting Common StockSale8,098US$28.041,596,423Direct
May 6, 2026Voting Common StockSale15,603US$29.131,580,820Direct

Source

View original at SEC

Related